<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">2-aminothiazole scaffold has emerged as a promising scaffold in medicinal chemistry and drug discovery research considering its broad pharmacological spectrum [
 <xref ref-type="bibr" rid="CR6">6</xref>]. Literature survey documented that 2-aminothiazole derivatives represent a class of heterocyclic ring system that possess antiviral [
 <xref ref-type="bibr" rid="CR7">7</xref>], antimicrobial [
 <xref ref-type="bibr" rid="CR8">8</xref>], anticancer [
 <xref ref-type="bibr" rid="CR9">9</xref>], anticonvulsant [
 <xref ref-type="bibr" rid="CR10">10</xref>], antidiabetic [
 <xref ref-type="bibr" rid="CR11">11</xref>], antihypertensive [
 <xref ref-type="bibr" rid="CR12">12</xref>], antileishmanial [
 <xref ref-type="bibr" rid="CR13">13</xref>], and anti-inflammatory activities [
 <xref ref-type="bibr" rid="CR14">14</xref>]. Also, in vitro anticancer evaluation studies of different 2-aminothiazole analogs exhibited their potent and selective nanomolar inhibitory activity against a wide range of human cancerous cell lines such as breast, leukemia, lung, colon, CNS, melanoma, ovarian, renal, and prostate [
 <xref ref-type="bibr" rid="CR15">15</xref>â€“
 <xref ref-type="bibr" rid="CR17">17</xref>].
</p>
